Teva Alleges Fraud In $2B Purchase Of Mexican Drug Co.

Law360, Los Angeles (September 27, 2016, 10:02 PM EDT) -- Teva Pharmaceuticals Industries Ltd. subsidiaries walloped two brothers who had sold their Mexican drug company to Teva with a $2.3 billion suit in New York state court Tuesday, saying the siblings hid the existence of unlawful products and evaded Mexico’s regulatory requirements.

The 52-page complaint comes less than a year after Teva Pharmaceuticals Holdings Mexico S.A. de C.V. acquired Representaciones E Investigaciones Medicas S.A. DE C.V., or Rimsa, from brothers Fernando Espinosa Abdala and Leopoldo De Jesus Espinosa Abdala for $2.3 billion, a deal that landed...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.